View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2014	Apr. 28, 2014
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1
Entity Registrant Name	HEALTHSTREAM INC
Entity Central Index Key	0001095565
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		27,564,606

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 59,045	$ 59,537
Marketable securities	42,952	48,659
Accounts receivable, net of allowance for doubtful accounts of $276 and $211 at March 31, 2014 and December 31, 2013, respectively	32,073	25,314
Accounts receivable -unbilled	1,427	1,392
Prepaid royalties, net of amortization	11,523	8,857
Other prepaid expenses and other current assets	3,231	3,365
Total current assets	150,251	147,124
Property and equipment:
Equipment	22,163	21,631
Leasehold improvements	5,806	5,521
Furniture and fixtures	4,138	3,854
Property and equipment, gross	32,107	31,006
Less accumulated depreciation and amortization	(22,918)	(21,968)
Total, property and equipment	9,189	9,038
Capitalized software development, net of accumulated amortization of $14,844 and $13,910 at March 31, 2014 and December 31, 2013, respectively	11,783	11,077
Goodwill	42,749	35,746
Intangible assets, net of accumulated amortization of $11,867 and $11,389 at March 31, 2014 and December 31, 2013, respectively	15,992	8,870
Other assets	995	739
Total assets	230,959	212,594
Current liabilities:
Accounts payable	2,914	2,311
Accrued royalties	10,907	8,435
Accrued liabilities	6,948	5,503
Accrued compensation and related expenses	1,291	1,614
Deferred tax liabilities, current	181	181
Deferred revenue	47,478	38,168
Total current liabilities	69,719	56,212
Deferred tax liabilities, noncurrent	6,173	6,173
Other long term liabilities	750	776
Commitments and contingencies
Shareholders' equity:
Common stock, no par value, 75,000 shares authorized; 27,565 and 27,327 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	169,816	166,888
Accumulated deficit	(15,476)	(17,424)
Accumulated other comprehensive loss	(23)	(31)
Total shareholders' equity	154,317	149,433
Total liabilities and shareholders' equity	$ 230,959	$ 212,594

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]
Allowance for doubtful accounts, net	$ 276	$ 211
Accumulated amortization on capitalized software development	14,844	13,910
Accumulated amortization on intangible assets	$ 11,867	$ 11,389
Common stock, no par value
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	27,565	27,327
Common stock, shares outstanding	27,565	27,327

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Revenues, net	$ 38,350	$ 29,646
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization)	16,926	12,520
Product development	3,546	2,606
Sales and marketing	6,947	5,199
Other general and administrative expenses	5,232	4,272
Depreciation and amortization	2,401	1,876
Total operating costs and expenses	35,052	26,473
Income from operations	3,298	3,173
Other income, net	45	47
Income before income tax provision	3,343	3,220
Income tax provision	1,395	1,279
Net income	$ 1,948	$ 1,941
Earnings per share:
Basic	$ 0.07	$ 0.07
Diluted	$ 0.07	$ 0.07
Weighted average shares of common stock outstanding:
Basic	27,453	26,340
Diluted	27,906	27,409

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 1,948	$ 1,941
Other comprehensive income, net of taxes:
Unrealized gain (loss) on marketable securities	8	(10)
Total other comprehensive income (loss)	8	(10)
Comprehensive income	$ 1,956	$ 1,931

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

+ Details

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (UNAUDITED) - 3 months ended Mar. 31, 2014 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance at Dec. 31, 2013	$ 149,433	$ 166,888	$ (17,424)	$ (31)
Beginning balance, shares at Dec. 31, 2013		27,327
Net income	1,948		1,948
Comprehensive income	8			8
Issuance of common stock in acquisition	2,247	$ 2,247
Issuance of common stock in acquisition, shares		82
Stock based compensation	384	$ 384
Common stock issued under stock plans, net of shares withheld for employee taxes	297	$ 297
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		156
Ending balance at Mar. 31, 2014	$ 154,317	$ 169,816	$ (15,476)	$ (23)
Ending balance, shares at Mar. 31, 2014		27,565

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
OPERATING ACTIVITIES:
Net income	$ 1,948	$ 1,941
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,401	1,876
Stock based compensation expense	384	310
Deferred income taxes	1,395	1,279
Provision for doubtful accounts	70	20
Other	376	308
Changes in operating assets and liabilities:
Accounts and unbilled receivables	(5,107)	(7,487)
Prepaid royalties	(2,667)	1,652
Other prepaid expenses and other current assets	140	(270)
Other assets	26	27
Accounts payable	604	230
Accrued royalties	2,472	(1,477)
Accrued liabilities and accrued compensation and related expenses and other long-term liabilities	(1,452)	167
Deferred revenue	8,599	5,279
Net cash provided by operating activities	9,189	3,855
INVESTING ACTIVITIES:
Acquisitions, net of cash acquired	(12,501)	(181)
Proceeds from maturities of investments in marketable securities	18,517	29,475
Purchases of investments in marketable securities	(13,176)	(29,552)
Investments in non-marketable equity investments	(250)
Payments associated with capitalized software development	(1,464)	(1,072)
Purchases of property and equipment	(1,104)	(744)
Net cash used in investing activities	(9,978)	(2,074)
FINANCING ACTIVITIES:
Proceeds from exercise of stock options	449	900
Taxes paid related to net settlement of equity awards	(152)	(158)
Net cash provided by financing activities	297	742
Net increase (decrease) in cash and cash equivalents	(492)	2,523
Cash and cash equivalents at beginning of period	59,537	41,365
Cash and cash equivalents at end of period	59,045	43,888
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock in connection with acquisition	$ 2,247

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2014
Accounting Policies [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (US GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, condensed consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated in consolidation. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. The balance sheet at December 31, 2013 is consistent with the audited financial statements at that date but does not include all of the information and footnotes required by US GAAP for a complete set of financial statements. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended December 31, 2013 (included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 4, 2014).

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228881-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2014
Income Tax Disclosure [Abstract]
INCOME TAXES	2. INCOME TAXES Income taxes are accounted for using the asset and liability method, whereby deferred tax assets and liabilities are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates that will be in effect for the year in which the differences are expected to affect taxable income. During the three months ended March 31, 2014 and 2013, the Company recorded a provision for income taxes of approximately $1.4 million and $1.3 million respectively. The Company’s effective tax rate for the three months ended March 31, 2014 and 2013 was 41.7% and 39.7%, respectively. The Company’s effective tax rate primarily reflects the statutory corporate income tax rate, the net effect of state taxes, and the effect of various permanent tax differences.

STOCK BASED COMPENSATION

3 Months Ended

Mar. 31, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

STOCK BASED COMPENSATION

3. STOCK BASED COMPENSATION

The Company maintains two stock incentive plans. The Company accounts for its stock based compensation plans using the fair-value based method for costs related to share-based payments, including stock options and restricted share units (RSUs). During the three months ended March 31, 2014, the Company issued 62,080 RSUs with a weighted average grant date fair value of $29.15 per share, measured based on the closing fair market value of the Company’s stock on the date of grant. During the three months ended March 31, 2013, the Company issued 77,750 RSUs with a weighted average grant date fair value of $21.70 per share, measured based on the closing fair market value of the Company’s stock on the date of grant.

Total stock based compensation expense recorded for the three months ended March 31, 2014 and 2013, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):


	Three Months Ended March 31,
	2014		2013
Cost of revenues (excluding depreciation and amortization)	$	17	$	16
Product development		44		34
Sales and marketing		47		36
Other general and administrative		276		224

Total stock based compensation expense	$	384	$	310

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

EARNINGS PER SHARE

4. EARNINGS PER SHARE

Basic earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing the net income for the period by the weighted average number of potentially dilutive common and common equivalent shares outstanding during the period. Common equivalent shares are composed of incremental common shares issuable upon the exercise of stock options and restricted share units subject to vesting. The dilutive effect of common equivalent shares is included in diluted earnings per share by application of the treasury stock method. The total number of common equivalent shares excluded from the calculations of diluted earnings per share, due to their anti-dilutive effect, was approximately 165,000 and 135,000 for the three months ended March 31, 2014 and 2013, respectively.

The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):


	Three Months Ended March 31,
	2014		2013
Numerator:
Net income	$	1,948	$	1,941

Denominator:
Weighted-average shares outstanding		27,453		26,340
Effect of dilutive shares		453		1,069

Weighted-average diluted shares		27,906		27,409


Basic earnings per share	$	0.07	$	0.07

Diluted earnings per share	$	0.07	$	0.07

MARKETABLE SECURITIES

3 Months Ended

Mar. 31, 2014

Investments Debt And Equity Securities [Abstract]

MARKETABLE SECURITIES

5. MARKETABLE SECURITIES

At March 31, 2014 and December 31, 2013, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):


	March 31, 2014
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,262	$	—	$	—		$	2,262
Corporate debt securities		40,713		3		(26	)		40,690

Subtotal		42,975		3		(26	)		42,952

Total	$	42,975	$	3	$	(26	)	$	42,952


	December 31, 2013
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,260	$	—	$	—		$	2,260
Corporate debt securities		46,430		—		(31	)		46,399

Subtotal		48,690		—		(31	)		48,659

Total	$	48,690	$	—	$	(31	)	$	48,659

The carrying amounts reported in the condensed consolidated balance sheet approximate the fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of March 31, 2014, the Company does not consider any of its marketable securities to be other than temporarily impaired. During the three months ended March 31, 2014 and 2013, the Company did not reclassify any items out of accumulated other comprehensive income to net income. All investments in marketable securities are classified as a current asset on the balance sheet because the underlying securities mature within one year from the balance sheet date.

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

BUSINESS COMBINATION	3 Months Ended
BUSINESS COMBINATION	Mar. 31, 2014
Business Combinations [Abstract]
BUSINESS COMBINATION	6. BUSINESS COMBINATION On March 3, 2014, the Company acquired all of the stock of Health Care Compliance Strategies, Inc. (HCCS), a Jericho, New York based company that specializes in healthcare compliance solutions and services. The Company acquired HCCS to further advance its suite of workforce development solutions, including its offering of compliance solutions. The consideration paid for HCCS consisted of approximately $13.0 million in cash and 81,614 shares of our common stock. The Company may make additional payments of up to $750,000, contingent upon the achievement of certain performance milestones within one year post-closing. The Company incurred approximately $500,000 in transaction costs associated with the acquisition, of which $350,000 were incurred during the three months ended March 31, 2014 and $150,000 were incurred during the year ended December 31, 2013. The transaction costs were recorded in other general and administrative expenses in the condensed consolidated statement of income. In allocating the purchase price, the Company has preliminarily recorded approximately $7.0 million of goodwill, $7.6 million of identifiable intangible assets, $2.5 million of tangible assets, and $1.1 million of liabilities. The goodwill balance is primarily attributed to assembled workforce, additional market opportunities of HCCS’s compliance solutions, and expected synergies from integrating HCCS’s products into our platform. The goodwill balance is deductible for U.S. income tax purposes. The allocation of purchase price is preliminary and may be subject to change within the measurement period of one year from the acquisition date. The primary areas of the preliminary purchase price allocation that are not finalized include the composition and valuation of intangible assets, goodwill, deferred revenue, and contingent consideration. The results of operations for HCCS have been included in the Company’s condensed consolidated financial statements from the date of acquisition, and are also included in the HealthStream Workforce Development Solutions segment.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

+ Details

BUSINESS SEGMENTS

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

BUSINESS SEGMENTS

7. BUSINESS SEGMENTS

The Company primarily provides services to healthcare organizations and other members within the healthcare industry. The Company’s services are primarily focused on the delivery of workforce development products and services (HealthStream Workforce Development Solutions), as well as survey and research services (HealthStream Research/Patient Experience Solutions). The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The Unallocated component below includes corporate functions, such as accounting, human resources, legal, investor relations, administrative, and executive personnel, depreciation, a portion of amortization, and certain other expenses, which are not currently allocated in measuring segment performance. The following is the Company’s business segment information as of and for the three months ended March 31, 2014 and 2013 (in thousands).


	Three Months Ended March 31,
	2014		2013
Revenues
Workforce Development	$	30,957	$	23,140
Research/Patient Experience		7,393		6,506

Total net revenue	$	38,350	$	29,646


	Three Months Ended March 31,
	2014			2013
Income from operations
Workforce Development	$	7,880		$	6,816
Research/Patient Experience		178			301
Unallocated		(4,760	)		(3,944	)

Total income from operations	$	3,298		$	3,173


	March 31, 2014		December 31, 2013
Segment assets*
Workforce Development	$	84,857	$	60,013
Research/Patient Experience		34,092		34,727
Unallocated		112,010		117,854

Total assets	$	230,959	$	212,594

Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

COLLABORATIVE ARRANGEMENT	3 Months Ended
COLLABORATIVE ARRANGEMENT	Mar. 31, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]
COLLABORATIVE ARRANGEMENT	8. COLLABORATIVE ARRANGEMENT The Company participates in a collaborative arrangement, SimVentures^TM, with Laerdal Medical A/S (Laerdal Medical). The Company receives 50 percent of the profits or losses generated from this collaborative arrangement. For the three months ended March 31, 2014, the Company has recorded approximately $0.4 million of revenues and $0.5 million of expenses related to the collaborative arrangement. For the three months ended March 31, 2013, the Company recorded approximately $0.4 million of revenues and $0.4 million of expenses related to the collaborative arrangement. The Company has also recorded approximately $0.2 million of capitalized software development for SimVentures during 2014.

STOCK BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income

Total stock based compensation expense recorded for the three months ended March 31, 2014 and 2013, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):


	Three Months Ended March 31,
	2014		2013
Cost of revenues (excluding depreciation and amortization)	$	17	$	16
Product development		44		34
Sales and marketing		47		36
Other general and administrative		276		224

Total stock based compensation expense	$	384	$	310

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):


	Three Months Ended March 31,
	2014		2013
Numerator:
Net income	$	1,948	$	1,941

Denominator:
Weighted-average shares outstanding		27,453		26,340
Effect of dilutive shares		453		1,069

Weighted-average diluted shares		27,906		27,409

Basic earnings per share	$	0.07	$	0.07

Diluted earnings per share	$	0.07	$	0.07

MARKETABLE SECURITIES (Tables)

3 Months Ended

Mar. 31, 2014

Investments Debt And Equity Securities [Abstract]

Fair Value of Available for Sale Marketable Securities

At March 31, 2014 and December 31, 2013, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):


	March 31, 2014
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,262	$	—	$	—		$	2,262
Corporate debt securities		40,713		3		(26	)		40,690

Subtotal		42,975		3		(26	)		42,952

Total	$	42,975	$	3	$	(26	)	$	42,952


	December 31, 2013
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Level 2:
Certificates of deposit	$	2,260	$	—	$	—		$	2,260
Corporate debt securities		46,430		—		(31	)		46,399

Subtotal		48,690		—		(31	)		48,659

Total	$	48,690	$	—	$	(31	)	$	48,659

BUSINESS SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Business Segment Information Based on Net Revenues and Net Income from Operations

The following is the Company’s business segment information as of and for the three months ended March 31, 2014 and 2013 (in thousands).


	Three Months Ended March 31,
	2014		2013
Revenues
Workforce Development	$	30,957	$	23,140
Research/Patient Experience		7,393		6,506

Total net revenue	$	38,350	$	29,646


	Three Months Ended March 31,
	2014			2013
Income from operations
Workforce Development	$	7,880		$	6,816
Research/Patient Experience		178			301
Unallocated		(4,760	)		(3,944	)

Total income from operations	$	3,298		$	3,173

Business Segment Information Based on Assets


	March 31, 2014		December 31, 2013
Segment assets *
Workforce Development	$	84,857	$	60,013
Research/Patient Experience		34,092		34,727
Unallocated		112,010		117,854

Total assets	$	230,959	$	212,594

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Tax Disclosure [Abstract]
Income tax provision	$ 1,395	$ 1,279
Effective tax rate	41.70%	39.70%

Stock Based Compensation - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014 Incentive_Plan $ / shares shares	Mar. 31, 2013 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans \| Incentive_Plan	2
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share units issued \| shares	62,080	77,750
Weighted average grant date fair value, restricted share unit \| $ / shares	$ 29.15	$ 21.70

Stock Based Compensation - Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$ 384	$ 310
Cost of Revenues (Excluding Depreciation and Amortization) [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	17	16
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	44	34
Sales and Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	47	36
Other General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$ 276	$ 224

Earnings Per Share - Additional Information (Detail) - shares	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Earnings Per Share [Abstract]
Total number of common equivalent shares excluded from the calculations of diluted earnings per share	165,000	135,000

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Numerator:
Net income	$ 1,948	$ 1,941
Denominator:
Weighted-average shares outstanding	27,453	26,340
Effect of dilutive shares	453	1,069
Weighted-average diluted shares	27,906	27,409
Basic earnings per share	$ 0.07	$ 0.07
Diluted earnings per share	$ 0.07	$ 0.07

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Marketable Securities - Fair Value of Available for Sale Marketable Securities (Detail) - USD ($) $ in Thousands	Mar. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Fair Value	$ 42,952	$ 48,659
Level 2 [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	42,975	48,690
Available for sale securities, Unrealized Gains	3
Available for sale securities, Unrealized Losses	(26)	(31)
Available for sale securities, Fair Value	42,952	48,659
Level 2 [Member] \| Certificates of Deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	2,262	2,260
Available for sale securities, Unrealized Gains
Available for sale securities, Unrealized Losses
Available for sale securities, Fair Value	2,262	2,260
Level 2 [Member] \| Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	40,713	46,430
Available for sale securities, Unrealized Gains	3
Available for sale securities, Unrealized Losses	(26)	(31)
Available for sale securities, Fair Value	$ 40,690	$ 46,399

Business Combination - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Purchase price allocation for goodwill	$ 42,749,000	$ 35,746,000
Health Care Compliance Strategies, Inc. [Member]
Business Acquisition [Line Items]
Acquisition date of assets	Mar. 03, 2014
Consideration paid for acquisition in cash	$ 13,000,000
Consideration paid for acquisition in shares	81,614
Additional consideration paid for acquisition in cash	$ 750,000
Contingent upon achievement of certain financial targets and business outcome, term	1 year
Transaction costs associated with the HCCS acquisition	$ 500,000
Transaction costs associated with the HCCS acquisition	350,000	$ 150,000
Purchase price allocation for goodwill	7,000,000
Purchase price allocation for identifiable intangible assets	7,600,000
Purchase price allocation for net tangible assets	2,500,000
Purchase price allocation for liabilities	$ 1,100,000
Preliminary purchase price allocation measurement period	1 year

Business Segments - Business Segment Information Based on Net Revenues and Net Income from Operations (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues
Total net revenue	$ 38,350	$ 29,646
Income from operations
Total income from operations	3,298	3,173
Operating Segments [Member] \| Workforce Development [Member]
Revenues
Total net revenue	30,957	23,140
Income from operations
Total income from operations	7,880	6,816
Operating Segments [Member] \| Research/Patient Experience [Member]
Revenues
Total net revenue	7,393	6,506
Income from operations
Total income from operations	178	301
Unallocated [Member]
Income from operations
Total income from operations	$ (4,760)	$ (3,944)

Business Segments - Business Segment Information Based on Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Total assets	$ 230,959	$ 212,594
Operating Segments [Member] \| Workforce Development [Member]
Segment Reporting Information [Line Items]
Total assets	84,857	60,013
Operating Segments [Member] \| Research/Patient Experience [Member]
Segment Reporting Information [Line Items]
Total assets	34,092	34,727
Unallocated [Member]
Segment Reporting Information [Line Items]
Total assets	$ 112,010	$ 117,854

Collaborative Arrangement - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Profits or losses received from collaborative arrangement	50.00%
Revenues related to collaborative arrangement	$ 400	$ 400
Expenses related to collaborative arrangement	500	400
Payments associated with capitalized software development	1,464	$ 1,072
SimVentures [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Payments associated with capitalized software development	$ 200